ReHeva Biosciences Advances Cancer Treatment With 80 Acres Farms’ Botanical Supply
Key Takeaways ReHeva Biosciences, a biopharmaceutical startup, has successfully concluded its Phase I Safety Trial for RH324, a drug aimed at enhancing the lives of cancer patients. In collaboration with Case […]